Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study

PURPOSE: To explore the safety and role of tegafur/gimeracil/oteracil (S1) maintenance therapy (MT) in metastatic nasopharyngeal carcinoma (NPC) patients after response to first-line chemotherapy and to assess outcome-associated biomarkers. METHODS: This was a multicentre, open-label, randomized con...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ying, Huang, Haixin, Yang, Hui, Hu, Xiaohua, Liu, Meilian, Huang, Changjie, Feng, Xianbin, Chen, Xishan, Jiang, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349704/
https://www.ncbi.nlm.nih.gov/pubmed/36075994
http://dx.doi.org/10.1007/s00432-022-04341-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349704/
https://www.ncbi.nlm.nih.gov/pubmed/36075994
http://dx.doi.org/10.1007/s00432-022-04341-2

Ejemplares similares